Genasense Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma
Data Presented at International Melanoma Conference inBerlin Results Follow Decision by Company to Continue Phase 3AGENDA Trial for Overall Survival BERKELEY HEIGHTS, N.J.–(BUSINESS WIRE)–Nov 20, 2009 – GentaIncorporated (OTCBB:…
November 20th, 2009
Posted in
Drug